毒素A型在初级下腺透症中的有效性和安全性:一个元分析和系统性审查
Jing Sun1, Shuangyu Chen2, Ting Yang3
1Department of Dermatology, Pidu District People's Hospital, The Third Affiliated Hospital of Chengdu Medical College, Chengdu, Sichuan, China.
Aesthetic plastic surgery
|June 11, 2025
概括
与安慰剂相比,毒素A型 (BTX-A) 注射有效地减少了与安慰剂相比,初级腹水症中的汗水. BTX-A的疗效与其他治疗方法相比,副作用较少,使其成为一种有价值的治疗选择.
科学领域:
- 皮肤病学 皮肤病学
- 医学美学 医学美学
背景情况:
- 主要下液过 (PAH) 是一个关于治疗疗效的持续辩论的疾病.
- 毒素A型 (BTX-A) 注射是一种潜在的PAH治疗干预措施.
研究的目的:
- 整合和分析关于BTX-A注射用于初级下腺透的证据.
- 与安慰剂和其他治疗方法相比,评估BTX-A的临床疗效和安全性.
主要方法:
- 按照PRISMA指南进行系统审查和元分析.
- 包括随机对照试验 (RCT),将BTX-A用于PAH与安慰剂或其他干预措施进行比较.
- 在2024年5月之前进行全面的文献搜索,然后进行定性和定量综合.
主要成果:
- 包括12项研究 (n=904) 在内. 与安慰剂相比,BTX-A显著减少了出汗 (P<0.05).
- BTX-A的疗效与其他治疗方法的汗水减少 (P=0.333) 和超症疾病严重程度量表 (HDSS) 评分 (P=0.413) 相当.
- 与其他治疗方法相比,BTX-A显示了可比的疼痛评分 (P=0.456) 和较少的副作用 (P<0.05).
结论:
- 与安慰剂相比,BTX-A注射有效地显著降低了与安慰剂相比,初级下腺透症的汗水产量.
- BTX-A的疗效与PAH的替代治疗方法相比,具有更好的安全性.
- "BTX-A"是一种安全有效的治疗方案,用于治疗原发性腹水症.
相关概念视频
01:26Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
660
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
660
01:27Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
401
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
401
01:19Depolarizing Blockers: Pharmocokinetics
315
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
315
01:14Assessing Body Temperature - Axilla
576
Procedural Guide for Assessing Axillary Body Temperature using a Digital Thermometer:
Step 1: Perform hand hygiene and put on clean gloves to maintain infection control and prevent cross-contamination.
Step 2: Prepare the patient by explaining the procedure to ensure understanding and cooperation. Ensure privacy, expose the axilla, and inform the patient that minimal movement is crucial for an accurate reading.
Step 3: Adjust the patient’s clothing to expose only the axilla. It minimizes...
Step 1: Perform hand hygiene and put on clean gloves to maintain infection control and prevent cross-contamination.
Step 2: Prepare the patient by explaining the procedure to ensure understanding and cooperation. Ensure privacy, expose the axilla, and inform the patient that minimal movement is crucial for an accurate reading.
Step 3: Adjust the patient’s clothing to expose only the axilla. It minimizes...
576
01:20Myasthenia Gravis: Overview and Treatment
1.2K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.2K
01:31Skeletal Muscle Relaxants: Therapeutic Uses
475
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
475